Key findings Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr
Ozempic (semaglutide) and Wegovy are the same compound at different doses
Brain NAD is associated with ATP energy production and membrane phospholipid turnover in humans
You get thoughtful, ongoing medical carenot a preset protocol
Remember that a test result is simply a mapit shows you where you are, but you decide where to go next
It plays a crucial role in neutralizing free radicals generated by factors like sun exposure, pollution, and lifestyle choices